The NFS calculation incorporates BMI, age, hyperglycaemia, AST/ALT ratio, albumin, and platelets, and was initially developed for 733 patients with biopsy-proven NAFLD (Table 4) [83]. The gene discussed is GPT; the disease is metabolic dysfunction-associated steatotic liver disease.